Group 1 - PayPay, a Japanese payments app backed by SoftBank, has filed for an initial public offering (IPO) in the United States, marking a significant step towards its public market debut [1] - This IPO will be the first U.S. listing of a SoftBank-majority investment since the successful IPO of chip designer Arm Holdings in 2023 [1] - The planned listing on Nasdaq under the symbol "PAYP" was initially expected in December but was delayed due to the longest-ever U.S. government shutdown affecting regulatory review [1] Group 2 - Goldman Sachs, J.P. Morgan, Mizuho, and Morgan Stanley are serving as the lead underwriters for PayPay's IPO [1]

Core Viewpoint - Coinbase's valuation metrics suggest it may be undervalued compared to peers, with a forward P/E of mid-teens and price/sales ratio of 6×, both significantly lower than industry averages [1] Company Overview - Coinbase Global, with a market cap of $43 billion, is the largest U.S. cryptocurrency exchange, providing a platform for trading, staking, and custody of digital assets [3] - The company serves both retail and institutional clients, boasting millions of verified users and trillions of dollars in assets on its platform [3] Recent Performance - COIN stock experienced a significant rally last year, peaking near $445 in mid-July before declining to the mid-$200s by year-end [2] - The stock has recently traded around $160-$165, reflecting a 32% drop in January due to broader crypto market weakness [2][5] Upcoming Earnings - Coinbase is set to release its Q4 2025 results on February 12, which is anticipated to be a critical event for investors [4][6] - Analysts expect Q4 revenue to be approximately $1.84 billion, down about 20% year-over-year, with EPS estimates around $0.99, significantly lower than the previous year's $3.50 [6] Guidance and Expectations - Management has guided for subscription and services revenue of $710 to $790 million for Q4, indicating a slight increase from Q3 [7] - Analysts are closely monitoring management's tone and guidance during the earnings call, as any signs of demand softening could negatively impact the stock [7] New Initiatives - Coinbase has launched new offerings, including a stock-trading service and a prediction-markets platform, aiming to enhance user engagement and diversify revenue sources [9][10] - The company is also acquiring The Clearing Company, marking its 10th acquisition in the year, which is part of its strategy to broaden its service offerings [10] Analyst Sentiment - Wall Street's consensus on Coinbase is a "Moderate Buy," with a 12-month target averaging around $337, suggesting over 100% upside potential from current levels [12] - Analysts have varying price targets, with Goldman Sachs raising its target to $310, while Cantor Fitzgerald and Mizuho have set lower targets due to anticipated 2025 weakness [12][13] Market Trends - Analysts emphasize the importance of Coinbase's new initiatives in driving user engagement, which could help stabilize its valuation amid volatile crypto trading [14][15] - The company's future performance is closely tied to cryptocurrency market trends, with the upcoming earnings call seen as a pivotal moment for its stock [15]

Core Insights - Solventum Corporation (NYSE:SOLV) is currently viewed as a highly profitable stock, with recent upgrades from Mizuho and Stifel indicating a positive outlook for the company and its market segments [1][2]. Group 1: Company Performance and Upgrades - Mizuho upgraded Solventum from Neutral to Outperform, raising its price target to $100 from $85, based on an optimistic outlook for the dental industry and increased patient volumes [1]. - Stifel also raised its price target for Solventum to $105 from $88 while maintaining a Buy rating, citing a favorable outlook for large-cap MedTech in 2026 [2]. Group 2: Acquisition Details - Solventum finalized its acquisition of Acera Surgical for an upfront cash payment of $725 million, with potential additional milestone payments of up to $125 million, aimed at enhancing its MedSurg portfolio in US acute care settings [3]. - The acquisition is expected to be slightly dilutive to adjusted EPS in 2026 but projected to become accretive starting in 2027 [3]. Group 3: Company Overview - Solventum Corporation develops, manufactures, and commercializes solutions addressing critical healthcare needs, operating in three segments: Medsurg, Dental Solutions, and Health Information Systems [4].

Investors may return to longer-dated Japanese debt after this weekend’s snap election, with big asset managers pinpointing 10-year yields reaching 2.5% as a possible trigger to buy, according to a Mizuho strategist https://t.co/T5hvxFaQ9z ...

Core Viewpoint - Applied Materials, Inc. (NASDAQ:AMAT) is experiencing significant growth, with shares up 78% over the past year and 19% year-to-date, driven by increased capital expenditure in wafer equipment globally [2]. Company Performance - Applied Materials is one of the largest semiconductor manufacturing equipment providers in the world [2]. - The company has received upgrades from Mizuho and Deutsche Bank, with Mizuho raising the price target to $370 from $275 and Deutsche Bank increasing it to $390 from $275 [2]. Market Dynamics - Major chip manufacturers like Intel and TSMC are aggressively investing in expanding their contract manufacturing capabilities, which benefits Applied Materials [2]. - There is a perceived shortage in wafer equipment, indicating strong demand for Applied Materials' products [3]. Analyst Sentiment - Analysts are attempting to catch up with the positive outlook for Applied Materials, with recent upgrades seen as a capitulation to the company's strong performance [3]. - Despite some market fluctuations, the overall demand for Applied Materials' offerings remains robust [3].

Group 1 - Rapid7 Inc. is considered one of the best small-cap tech stocks to invest in currently, with recent price target adjustments from analysts [1] - Mizuho analyst Gregg Moskowitz reduced the price target for Rapid7 from $20 to $16 while maintaining a Neutral rating, citing valuation compression as a primary driver [1][2] - Truist also lowered its price target for Rapid7 from $18 to $14 with a Hold rating, anticipating strong Q4 results but conservative guidance for 2026 [3] Group 2 - The firm noted solid public cloud performance and strong AI adoption, but expressed concerns over moderate budget activity and the impact of AI-related disruption on software company multiples [2] - Despite steady demand from IT budget holders, software equities, including Rapid7, face significant headwinds [3] - Rapid7 provides cybersecurity software and services under various brand names, including Rapid7, Nexpose, and Metasploit [4]

Core View - CoreWeave Inc. (NASDAQ:CRWV) is experiencing a rise in stock value, with Deutsche Bank upgrading its rating to Buy from Hold and increasing the price target to $140 from $100, citing a solid medium-term outlook leading into the Q4 2025 report [1] - Mizuho analyst also raised the price target for CoreWeave to $100 from $92 while maintaining a Neutral rating, following the announcement of an expanded relationship with Nvidia Corporation to accelerate a 5GW capacity build-out and an additional $2 billion equity investment [2][3] Company Operations - CoreWeave operates a cloud platform that provides scaling, support, and acceleration for Generative AI, building infrastructure that supports compute workloads for enterprises [4]

Company Overview - Sandisk Corporation (NASDAQ:SNDK) has seen its shares rise by triple-digit percentages since early 2025, indicating strong market performance [2] - Analysts have recently increased their price targets for Sandisk, with Mizuho raising it to $600 from $410 while maintaining an Outperform rating [2] - Benchmark also raised its price target for Sandisk to $450 from $260, keeping a Buy rating, citing capacity issues in the NAND market as a driving factor [2] Industry Insights - The NAND and DRAM product sectors are experiencing pricing power, which is beneficial for Sandisk [2] - A significant factor noted by analysts is the expected shortage of NAND wafer capacity in 2026 and 2027, potentially leading to a 330% price increase in 2026 [2] - Jim Cramer highlighted that Sandisk's recent performance issues are due to an inability to meet demand rather than a lack of demand, emphasizing the importance of capacity in the market [3]

Core Insights - Marqeta Inc. (NASDAQ:MQ) has demonstrated a strong revenue growth of 20.11% over the past 12 months, but analysts have downgraded the stock rating to Neutral from Outperform and reduced the price target to $4.50 from $8 [1] - The company is projected to experience a 22% growth for fiscal year 2025, although it faces challenges such as the transition of Cash App Card's new issuance to Bancorp, which may impact its competitive position [1] - Wolfe Research has also downgraded Marqeta's rating to Peerperform from Outperform, citing similar headwinds and noting a 60% volume growth in the company's lending and buy-now-pay-later services in Q3 2025 [2] Company Overview - Marqeta Inc. specializes in the digital payment technology sector, offering a modern card issuing platform that provides infrastructure and tools for configurable payment cards, card issuer processing, and card program management services [3]

Mizuho upgrades Circle shares outlook citing Polymarket’s use of USDC for settlement https://t.co/0DdMgrAdHr ...